REDWOOD CITY, Calif., February 27, 2025--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with ...
Hosted on MSN1mon
arcellx director kavita patel sells $96,854 in stockKavita Patel, a director at Arcellx , Inc. (NASDAQ:ACLX), recently sold a portion of her holdings in the company. According to a recent SEC filing, Patel sold 1,500 shares of Arcellx common stock ...
Barclays analyst Peter Lawson maintained a Buy rating on Arcellx Inc (ACLX – Research Report) today and set a price target of $115.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback